Why is a nanotech based drug most effective as cancer cure ?
Cancer is a complex and evolving disease . As of today , there is no specific and selective drug for cancer . Blood vessels in tumors are “ leaky ” because they have gaps from 200-2000 nm , which allow nanoparticles to escape into the tumor . Nanometer sized particles than standalone . Researchers have been studying on new phytochemical and their synthetic analogues which can fight against cancer and counter the side effects caused by the current chemo and radition methods .
Safer cancer medicine will have profound impact on the patients and their caregivers . One can untapped for these phytochemicals to develop them as drugs . With the support of more venture funds , we can develop scientifically validated formulations to meet the regulatory guidelines using nanotechnology approaches .
Owing to their relatively lower drug toxicity and greater efficacy nano-herbal medicines are in high demand especially as anticancer combination drugs . It is the high time to apply modern methodologies to revise and standardize the ancient knowledge to tackle emerging global health care challenges such as multi drug resistance antibiotics and cancers .
below 500nm can promote tumor selectivity and aid in delivering low-solubility drugs . Nanoparticles can be targeted passively or actively . Passive targeting exploits the difference between tumor blood vessels and normal blood vessels . In the current cancer care , chemotherapy , radiation therapy , hypothermia has been used in-combination more often debate the standalone therapeutic efficacy of herbal drugs however their adjuvant synergistic effects are indispensable for current cancer care and much research is needed to develop as mainstream drugs using nanotechnology approaches . Given the unmet need of cancer patients by current standard of care , there is a great opportunity waiting to be
Dr Vijay Kanuru is a serial entrepreneur , leads management strategy , technology innovation and execution to achieve business goals by identifying , prioritizing and implementing both technology and business development portfolios . As the Founder and CEO of Oncocur India Pvt Ltd , his vision and passion are the key driving forces in establishing a visionary pre-eminent cancer nanomedicine company , develops novel nano drug targets for the treatment of cancer . Vijay did his PhD from the University of Cambridge and doctoral studies focuses on surface chemistry of nanostructures .
BIOVOICENEWS . COM 25